Correlation Between Synaptogenix and Inhibikase Therapeutics
Can any of the company-specific risk be diversified away by investing in both Synaptogenix and Inhibikase Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Synaptogenix and Inhibikase Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Synaptogenix and Inhibikase Therapeutics, you can compare the effects of market volatilities on Synaptogenix and Inhibikase Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Synaptogenix with a short position of Inhibikase Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Synaptogenix and Inhibikase Therapeutics.
Diversification Opportunities for Synaptogenix and Inhibikase Therapeutics
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Synaptogenix and Inhibikase is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Synaptogenix and Inhibikase Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibikase Therapeutics and Synaptogenix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Synaptogenix are associated (or correlated) with Inhibikase Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibikase Therapeutics has no effect on the direction of Synaptogenix i.e., Synaptogenix and Inhibikase Therapeutics go up and down completely randomly.
Pair Corralation between Synaptogenix and Inhibikase Therapeutics
Given the investment horizon of 90 days Synaptogenix is expected to generate 0.74 times more return on investment than Inhibikase Therapeutics. However, Synaptogenix is 1.35 times less risky than Inhibikase Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Inhibikase Therapeutics is currently generating about 0.07 per unit of risk. If you would invest 285.00 in Synaptogenix on September 4, 2024 and sell it today you would earn a total of 28.00 from holding Synaptogenix or generate 9.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Synaptogenix vs. Inhibikase Therapeutics
Performance |
| Timeline |
| Synaptogenix |
| Inhibikase Therapeutics |
Synaptogenix and Inhibikase Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Synaptogenix and Inhibikase Therapeutics
The main advantage of trading using opposite Synaptogenix and Inhibikase Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Synaptogenix position performs unexpectedly, Inhibikase Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibikase Therapeutics will offset losses from the drop in Inhibikase Therapeutics' long position.| Synaptogenix vs. Annovis Bio | Synaptogenix vs. Cyclo Therapeutics | Synaptogenix vs. Reviva Pharmaceuticals Holdings | Synaptogenix vs. INmune Bio |
| Inhibikase Therapeutics vs. Candel Therapeutics | Inhibikase Therapeutics vs. Cingulate Warrants | Inhibikase Therapeutics vs. Unicycive Therapeutics | Inhibikase Therapeutics vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |